Abstract
Although the number of clinical trials for patients with COVID-19 is increasing, many exclude pregnant women as participants or do not address pregnancy. This commentary discuss why pregnancy women should be included in clinical trials of interventions for COVID-19.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have